Oncological and functional outcomes following open radical prostatectomy: How patients may achieve the "trifecta"?

International Braz J Urol

Volumn 37, Issue 3, 2011, Pages 320-327

  Antebi, Elie ^a   Eldefrawy, Ahmed ^a   Katkoori, Devendar ^a   Soloway, Cynthia T ^a   Manoharan, Murugesan ^a   Soloway, Mark S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate cancer; Radical Prostatectomy; Recurrence; Treatment outcome

Indexed keywords

ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ARTICLE; ERECTILE DYSFUNCTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; PROSTATECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE; URINE INCONTINENCE;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 80051879005     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382011000300005     Document Type: Article

References (24)

1. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC: Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am. 2001; 28: 555-65.
2. Walsh PC, Donker PJ: Impotence following radical prostatectomy: insight into etiology and prevention. 1982. J Urol. 2002; 167: 1005-10.
3. Walsh PC: Anatomic radical prostatectomy: evolution of the surgical technique. J Urol. 1998; 160: 2418-24.
4. Bianco FJ Jr, Scardino PT, Eastham JA: Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (" trifecta"). Urology. 2005; 66(5 Suppl): 83-94.
5. Eastham JA, Kattan MW, Rogers E, Goad JR, Ohori M, Boone TB, et al.: Risk factors for urinary incontinence after radical prostatectomy. J Urol. 1996; 156: 1707-13.
6. Walsh PC, Marschke P, Ricker D, Burnett AL: Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology. 2000; 55: 58-61.
7. Litwin MS, Pasta DJ, Yu J, Stoddard ML, Flanders SC: Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2000; 164: 1973-7.
8. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al.: Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995; 273: 129-35.
9. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, et al.: Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000; 283: 354-60.
10. Lepor H, Kaci L, Xue X: Continence following radical retropubic prostatectomy using self-reporting instruments. J Urol. 2004; 171: 1212-5.
11. Cappelleri JC, Siegel RL, Glasser DB, Osterloh IH, Rosen RC: Relationship between patient selfassessment of erectile dysfunction and the sexual health inventory for men. Clin Ther. 2001; 23: 1707-19.
12. Abrams P, Avery K, Gardener N, Donovan J; ICIQ Advisory Board: The International Consultation on Incontinence Modular Questionnaire: www. iciq.net. J Urol. 2006; 175: 1063-6; discussion 1066.
13. D'Amico AV, Whittington R, Malkowicz SB, Weinstein M, Tomaszewski JE, Schultz D, et al.: Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol. 2001; 166: 2185-8.
14. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al.: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998; 280: 969-74.
15. Tsivian M, Mayes JM, Krupski TL, Mouraviev V, Donatucci CF, Polascik TJ: Altered male physiologic function after surgery for prostate cancer: couple perspective. Int Braz J Urol. 2009; 35: 673-82.
16. Eastham JA, Scardino PT, Kattan MW: Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. J Urol. 2008; 179: 2207-10; discussion 2210-11.
17. Pierorazio PM, Spencer BA, McCann TR, McKiernan JM, Benson MC: Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy. Urology. 2007; 70: 717-22.
18. Shikanov SA, Zorn KC, Zagaja GP, Shalhav AL: Trifecta outcomes after robotic-assisted laparoscopic prostatectomy. Urology. 2009; 74: 619-23.
19. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH: The UCLA Prostate Cancer Index: development, reliability, and validity of a healthrelated quality of life measure. Med Care. 1998; 36: 1002-12.
20. Pettus JA, Masterson T, Sokol A, Cronin AM, Savage C, Sandhu JS, et al.: Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy. J Urol. 2009; 182: 949-55.
21. Tal R, Konichezky M, Baniel J: Impact of prostate weight on radical prostatectomy outcomes. Isr Med Assoc J. 2009; 11: 354-8.
22. Foley CL, Bott SR, Thomas K, Parkinson MC, Kirby RS: A large prostate at radical retropubic prostatectomy does not adversely affect cancer control, continence or potency rates. BJU Int. 2003; 92: 370-4.
23. Frota R, Turna B, Santos BM, Lin YC, Gill IS, Aron M: The effect of prostate weight on the outcomes of laparoscopic radical prostatectomy. BJU Int. 2008; 101: 589-93.
24. Ahlering TE, Kaplan AG, Yee DS, Skarecky DW: Prostate weight and early potency in robot-assisted radical prostatectomy. Urology. 2008; 72: 1263-8.